Gene · 1294
Papers2,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell transcriptomics profiling elucidates RBP-driven metastatic signaling pathways in ER+ breast cancer. | iScience | 2026 | 42256294 | PubTator, text mining | PubMed |
| Comparative effects of hyaluronic acid-amino acid and polynucleotide mixtures on extracellular matrix gene expression in human dermal fibroblasts. | J Wound Care | 2026 | 42247333 | PubTator, text mining | PubMed |
| Leveraging Whole-Exome Sequencing to Decipher the Genetic Landscape of Three Genodermatoses' Cases in Middle Eastern Pediatric Patients. | Genes (Basel) | 2026 | 42194992 | PubTator, text mining | PubMed |
| Case Report: Successful treatment of dystrophic epidermolysis bullosa pruriginosa with upadacitinib in a patient with COL7A1, CARD14, and G6PD gene mutations. | Front Med (Lausanne) | 2026 | 42180729 | PubTator, text mining | PubMed |
| MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics. | Front Immunol | 2026 | 42164509 | PubTator, text mining | PubMed |
| Bullous Systemic Lupus Erythematosus in a Male Child With Lupus Nephritis: A Rare Pediatric Presentation. | Cureus | 2026 | 42083672 | PubTator, text mining | PubMed |
| Diagnostic challenge: Epidermolysis bullosa acquisita of the palms and soles. | Clin Exp Dermatol | 2026 | 42077114 | PubTator, text mining | PubMed |
| Reproductive Genetic Carrier Screening in Romania: A Couple-Based Study of Pathogenic Molecular Variants. | Int J Mol Sci | 2026 | 42074219 | PubTator, text mining | PubMed |
| Integrated clinicopathological, genomic, and immunophenotypic landscape of renal tubulocystic oncocytoma. | Front Immunol | 2026 | 42058215 | PubTator, text mining | PubMed |
| Gene Expression Alterations Associated With Resveratrol-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Osteosarcoma Cancer Cells. | J Cell Mol Med | 2026 | 41937498 | PubTator, text mining | PubMed |
| Innovations in topical epidermolysis bullosa treatment: integrating advanced dressings, bioactive therapies and tissue-engineered skin. | Daru | 2026 | 41931158 | PubTator, text mining | PubMed |
| Lupus erythematosus-specific bullous lesions: A case report. | Medicine (Baltimore) | 2026 | 41894261 | PubTator, text mining | PubMed |
| Molecular Markers Distinguishing Early-Stage Mycosis Fungoides From Atopic Dermatitis Skin Lesions. | Exp Dermatol | 2026 | 41888970 | PubTator, text mining | PubMed |
| Chromatin accessibility regulates age-dependent nuclear mechanotransduction. | Proc Natl Acad Sci U S A | 2026 | 41886372 | PubTator, text mining | PubMed |
| The extracellular matrix: structure, composition, biological functions, diseases, and therapeutic targets. | Mol Biomed | 2026 | 41886037 | PubTator, text mining | PubMed |
| Refractory linear IgA dermatosis in childhood: a successful response to rituximab. | An Bras Dermatol | 2026 | 41875725 | PubTator, text mining | PubMed |
| Systemic inflammation in recessive dystrophic epidermolysis bullosa: a five-year longitudinal study. | Br J Dermatol | 2026 | 41787717 | PubTator, text mining | PubMed |
| Observations of dystrophic epidermolysis bullosa patients with collagen VII NC2 truncation provide new insights into anchoring fibril assembly. | Matrix Biol | 2026 | 41786094 | PubTator, text mining | PubMed |
| An evaluation of prademagene zamikeracel for the treatment of recessive dystrophic epidermolysis bullosa. | Expert Opin Biol Ther | 2026 | 41764660 | PubTator, text mining | PubMed |
| Mechanistic machine learning enables interpretable and generalizable prediction of prime editing outcomes. | bioRxiv | 2026 | 41757025 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1294/papers?page=2